Results 221 to 230 of about 168,749 (376)

Sex‐related pathophysiological mechanisms may be present before symptoms of HFpEF develop

open access: yesESC Heart Failure, EarlyView.
Abstract Aims Understanding sex‐related cardiovascular differences in those with pre‐HFpEF (asymptomatic with normal ejection fraction, elevated natriuretic peptides and structural or functional heart disease) could help explain why females are more likely to develop symptomatic HFpEF compared with males.
B. Wong   +6 more
wiley   +1 more source

Transient Ischemic Attack Due to Dissection of the Middle Cerebral Artery. Case Report.

open access: gold, 2001
Yasushi Iwamuro   +5 more
openalex   +2 more sources

Validation of a biomarker‐based mortality score for cardiogenic shock patients: Comparison with a clinical risk score

open access: yesESC Heart Failure, EarlyView.
Abstract Aims Cardiogenic shock (CS) is the deadliest manifestation of acute heart failure, with persistently high mortality rates and a lack of recent therapeutic breakthroughs. Accurate risk prediction is crucial in clinical decision‐making and the design of future clinical trials.
Elina Hynninen   +14 more
wiley   +1 more source

AASLD practice guidance on drug, herbal, and dietary supplement–induced liver injury

open access: yes, 2022
Hepatology, EarlyView.
Robert J. Fontana   +6 more
wiley   +1 more source

Outcome of primary closure following carotid endarterectomy with a novel technique: An 8-year multicenter cohort study

open access: yesJournal of Vascular Surgery Cases and Innovative Techniques
This study evaluated the safety and efficacy of a novel primary closure technique in carotid endarterectomy compared with traditional methods. Conducted over 8 years at three university hospitals, this study included 184 patients.
Amir Ahmad Arabzadeh, MD   +3 more
doaj  

Headache at Stroke Onset in 2196 Patients With Ischemic Stroke or Transient Ischemic Attack [PDF]

open access: bronze, 2004
Susanne Tentschert   +4 more
openalex   +1 more source

Burst steroid therapy and quality of life in patients with acute heart failure: Insights from the CORTAHF trial

open access: yesESC Heart Failure, EarlyView.
Abstract Aims Patients hospitalized with acute heart failure (AHF) treated with a 7 day prednisone course in the CORTAHF pilot trial had a greater improvement in health‐related quality of life (QoL) at Day 7 in both the overall population and in patients with baseline interleukin 6 > 13 pg/mL.
Matteo Pagnesi   +21 more
wiley   +1 more source

Home - About - Disclaimer - Privacy